The world had been anticipating another influenza pandemic since the last one in 1968. The
pandemic influenza A H1N1 2009 virus (A/2009/H1N1) finally arrived, causing the first …

Passive immunization with polyclonal hyper immunoglobulin (HIG) therapy represents a
proven strategy by transferring immunoglobulins to patients to confer immediate protection …

Abstract A (H1N1) pdm09 influenza A viruses predominated in the 2013–2014 USA
influenza season, and although most of these viruses remain sensitive to Food and Drug …

The ongoing COVID-19 pandemic has infected nearly 3,582,233 individuals with 248,558
deaths since it was first identified in human populations in December 2019 in Wuhan, China …

ABSTRACT Introduction: Pooled human immunoglobulins (IGs) are prepared from plasma
obtained from healthy donors as a concentrated antibody-containing solution. In addition …

Yearly administration of the influenza vaccine is the main strategy to prevent influenza in
immunocompromised patients. Here, we reviewed the recent literature regarding the clinical …

Background and purpose Severe influenza is defined as influenza with a severe symptom or
syndrome such as respiratory distress or deceased consciousness or accompanying a …

Despite improvements in the management of community-acquired pneumonia (CAP),
morbidity and mortality are still high, especially in patients with more severe disease. Early …

Purpose To provide prognosis of an 18 patient cohort who were confirmed to have H7N9
lung infection in Shanghai. Methods Patients' history, clinical manifestation, laboratory test …

Both seasonal and pandemic influenza cause considerable morbidity and mortality globally.
In addition, the ongoing threat of new, unpredictable influenza pandemics from emerging …